Kim Ryan

Advocacy in Action: Lack of Consensus & the Validity of Progression-Free Survival
Jun
28
2011

This discussion is led by Regina Vidaver, Exec. Dir. of the Nat’l Lung Cancer Partnership. Featuring Cancer Advocates: Selma Schimmel (Vital Options International), Prof. David Kerr (President of ESMO), Diane Blum (Lymphoma Research Foundation), Kim Ryan (Fight Colorectal Cancer), Cara Tenenbaum (Ovarian Cancer National Alliance), and Ginny Mason (Inflammatory Breast Cancer Research Foundation). The Group […]

Read More
Role of Global Advocate Community in Research & Clinical Trials
Jun
28
2011

This discussion is led by Prof. David Kerr (President of ESMO), Diane Blum (CEO Lymphoma Research Foundation), Regina Vidaver (Exec. Dir. of the Nat’l Lung Cancer Partnership) and Selma Schimmel (Founder & CEO Vital Options International. Featuring Cancer Advocates: Arin Assero (International Myeloma Foundation), Andrea Evans (Y-Me National Breast Cancer Foundation) and Kim Ryan (Fight […]

Read More
Drug Shortages in Cancer Care
Jun
28
2011

This discussion is led by Diane Blum (CEO Lymphoma Research Foundation) and addresses the recent drug shortage issues specifically for cancer patients and how advocate organizations are handling it. Featuring Cancer Advocates: Cara Tenenbaum (Ovarian Cancer National Alliance), Kim Ryan (Fight Colorectal Cancer), Prof. David Kerr (President of ESMO), Eric Rosenthal (Oncology Times) and Selma […]

Read More